Amporin Pharmaceuticals AG

Amporin Pharmaceuticals AG is a new biotech startup founded in Basel 2024 by a small team of industry-seasoned drug development experts. We are developing a breakthrough new class of small molecule drugs that can protect and repair cell membranes as the first potential acute oral disease-modifying treatments for deadly degenerative diseases associated with protein misfolding and aggregation. Our vision is to cure 6 degenerative diseases with a simple pill, starting with Parkinson’s disease and ALS, while our preliminary animal data suggests that this is already possible.

Website